References
Vazquez E, Lucaya J, Castellote A, Piqueras J, Sainz P, Olive T, Sanchez-Toledo J, Ortega JJ (2002) Neuroimaging in pediatric leukemia and lymphoma: differential diagnosis. Radiographics 22(6):1411–1428. https://doi.org/10.1148/rg.226025029
Baehring JM, Fulbright RK (2008) Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry 79(5):535–539. https://doi.org/10.1136/jnnp.2007.123737
Quinn CT, Griener JC, Bottiglieri T, Hyland K, Farrow A, Kamen BA (1997) Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol 15(8):2800–2806. https://doi.org/10.1200/JCO.1997.15.8.2800
Quinn CT, Griener JC, Bottiglieri T, Arning E, Winick NJ (2004) Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid. J Pediatr Hematol Oncol 26(6):386–388
Bernini JC, Fort DW, Griener JC, Kane BJ, Chappell WB, Kamen BA (1995) Aminophylline for methotrexate-induced neurotoxicity. Lancet 345(8949):544–547
Tsujimoto S, Yanagimachi M, Tanoshima R, Urayama KY, Tanaka F, Aida N, Goto H, Ito S (2016) Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies. Pediatr Blood Cancer 63(11):1983–1989. https://doi.org/10.1002/pbc.26090
Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, Krull KR, Inaba H, Rubnitz JE, Metzger ML, Howard SC, Ribeiro RC, Cheng C, Reddick WE, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV (2014) Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 32(9):949–959. https://doi.org/10.1200/JCO.2013.53.0808
Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18(17):3144–3150. https://doi.org/10.1200/JCO.2000.18.17.3144
Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Roth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithauser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nagele T, Pietsch T, Bamberg M, Weller M (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11(11):1036–1047. https://doi.org/10.1016/S1470-2045(10)70229-1
Watanabe K, Arakawa Y, Oguma E, Uehara T, Yanagi M, Oyama C, Ikeda Y, Sasaki K, Isobe K, Mori M, Hanada R, Koh K (2018) Characteristics of methotrexate-induced stroke-like neurotoxicity. Int J Hematol 108(6):630–636. https://doi.org/10.1007/s12185-018-2525-0
Agarwal A, Vijay K, Thamburaj K, Ouyang T (2011) Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke. Emerg Radiol 18(4):345–347. https://doi.org/10.1007/s10140-010-0931-6
Yang J, Kim GS, Park HM (2015) A unique radiological case of intrathecal methotrexate-induced toxic leukoencephalopathy. J Neurol Sci 353(1–2):169–171. https://doi.org/10.1016/j.jns.2015.04.001
Iwatani K, Fujii N, Deguchi S, Tanimoto M (2012) Subacute methotrexate-related leukoencephalopathy with stroke-like presentation. Int J Hematol 96(6):683–684. https://doi.org/10.1007/s12185-012-1194-7
Cruz-Carreras MT, Chaftari P, Shamsnia A, Guha-Thakurta N, Gonzalez C (2017) Methotrexate-induced leukoencephalopathy presenting as stroke in the emergency department. Clin Case Rep 5(10):1644–1648. https://doi.org/10.1002/ccr3.1110
Drachtman RA, Cole PD, Golden CB, James SJ, Melnyk S, Aisner J, Kamen BA (2002) Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol 19(5):319–327. https://doi.org/10.1080/08880010290057336
Rogers P, Pan WJ, Drachtman RA, Haines C (2017) A stroke mimic: methotrexate-induced neurotoxicity in the emergency department. J Emerg Med 52(4):559–561. https://doi.org/10.1016/j.jemermed.2016.11.016
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Roderick Maas, Sjoert Pegge, Dorothea Evers, and Anusha van Samkar report no disclosures.
Karin Klijn is supported by a clinical established investigator grant from the Dutch Heart Foundation (2012T077) and an Aspasia grant from ZonMw.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Maas, R.P.P.W.M., Pegge, S.A.H., Evers, D. et al. Methotrexate-induced toxic leukoencephalopathy: an uncommon stroke mimic. Neurol Sci 40, 1307–1309 (2019). https://doi.org/10.1007/s10072-019-3711-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-3711-4